Aktuelle Nachrichten über Humatica, unsere Mitarbeiter, Projekte und Veranstaltungen. Für weitere Updates besuchen Sie gerne unsere LinkedIn-Seite.
Zu unseren InsightsHumatica, the leading private equity specialist advisor for portfolio organisational effectiveness, has advised private equity firm Baird Capital on its acquisition of a majority interest in eCube Solutions Limited, a leading aircraft disassembly…
Read moreHumatica AG was retained to advise Capvis on its majority investment stake in Xovis, the global leader in people flow measurement and analytics. With the…
Read moreHumatica Ltd. was retained to advise the Riverside Company on its significant investment in E&A Scheer (Scheer), the largest global blender and vendor of premium…
Read moreHumatica AG was retained to advise Summa Equity on its majority investment in Infobric AB (“Infobric”), a provider of software and hardware for attendance systems,…
Read moreHumatica AG was retained to advise Summa Equity on its majority investment in Lakers Holding AB (“Lakers”), a Nordic group operating within the water, wastewater,…
Read moreHumatica has supported Solifos AG’s management and HVD Partners with the carve out and rapid turn-around of the former Brugg Cables company active in fiber…
Read moreHumatica AG was retained to advise Capvis on its majority investment in Austrian firm AMANN GIRRBACH AG, a pioneer in dental CAD/CAM technology. The firm…
Read moreHumatica Ltd. was retained to advise Baird Capital on its acquisition of a majority interest in Collingwood Lighting, a leading designer and supplier of residential,…
Read moreHumatica Ltd. was retained to advise the Riverside Company on its investment in Swiss manufacturer TECSEDO RE through Panels S.A., a portfolio holding of The…
Read moreHumatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products…
Read more